Showing results (401-410 of 499) with videos related to

Sort By:
Pageof 50
BMJ Open|January 16, 2015
Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)P Warner, C J Weir, C H Hansen, et al.
Health Technology Assessment (Winchester, England)|November 15, 2025
An exploration of the factors influencing successful implementation, delivery and outcomes in an intensive care sedation study: process evaluation of the A2B RCTLeanne M Aitken, Lydia M Emerson, Kalliopi Kydonaki, et al.
International Journal of Molecular Sciences|April 13, 2023
Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic CancerSangita Bhattacharyya, Hindole Ghosh, Obdulia Covarrubias-Zambrano, et al.
Acta Neuropathologica Communications|February 21, 2018
Cooperative p16 and p21 action protects female astrocytes from transformationNajla Kfoury, Tao Sun, Kwanha Yu, et al.
BMJ Open|April 5, 2024
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B trial): protocol for a mixed-methods process evaluation of a randomised controlled trialLeanne M Aitken, Lydia M Emerson, Kalliopi Kydonaki, et al.
Oncotarget|September 28, 2016
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesisFernando F Blanco, Ranjan Preet, Andrea Aguado, et al.
Chemical Research in Toxicology|May 17, 2005
Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomesChing Yu Lin, Margaret A Isbell, Dexter Morin, et al.
Cell Death & Disease|May 25, 2024
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancerDavid Standing, Prasad Dandawate, Sumedha Gunewardena, et al.
Oncogene|December 23, 2014
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionM Mura, T G Hopkins, T Michael, et al.
Critical Care Medicine|February 23, 2016
Development of Process Control Methodology for Tracking the Quality and Safety of Pain, Agitation, and Sedation Management in Critical Care UnitsTimothy S Walsh, Kalliopi Kydonaki, Robert J Lee, et al.
Pageof 50